Skip to content
Two platforms

Platform 01 · Native Biologics · Cell-selected

Preserve the biological complexity of selected producer cells.

This platform is appropriate when the coordinated, multi-molecular signalling environment of native cell biology is what the application needs. It generates EV-rich conditioned media and purified extracellular-vesicle preparations from source-cell populations chosen on defined glutathione and homogeneity parameters.
Source
Human umbilical cord MSC
Selection
GM · GH · GRC · ORC
Culture
Phenol red-free, ACF
Outputs
Powder & CM

Level 01Source · comparative biology

The source matters. Source alone is not a quality certificate.

Comparative proteomic studies show real, source-dependent differences in cargo and biological activity. That is why PEXT starts from umbilical cord tissue. It is also why PEXT does not stop there.
  • Perinatal / umbilical cord

    Wharton's jelly MSC

    PEXT source

    Ethically donated umbilical cords. The youngest, most robust multipotent mesenchymal stromal cells available.

    High concentration of growth factors, cytokines and miRNA. Relevant to both skin and scalp tissue.

    Highest

    Lowest immunogenicity profile. Day-zero cellular vitality.

  • Adipose-derived

    Adult fat tissue

    Widely used across aesthetic brands. Readily available in volume.

    Effective for superficial hydration, mild wound healing and general anti-ageing applications.

    Moderate

    Parent cells carry biological ageing and decades of oxidative exposure.

  • Bone marrow

    Traditional MSC source

    The historic source of stem cells, long used in orthopaedic regenerative medicine.

    Strong osteogenic and angiogenic properties. Used in concentrated repair serums.

    Moderate to niche

    Extraction is highly invasive; donor cells are biologically aged.

  • Plant-derived

    Botanical / marine

    Vesicle-like nanoparticles from botanical or marine sources. Abundant and scalable.

    High in antioxidants; soothing and moisturizing.

    Lowest for structural repair

    A biologically different and less clinically mature category than human MSC-derived EVs.

No source is universally superior for every application. Donor condition, cellular age, population heterogeneity, passage number and culture environment can matter as much as the name of the tissue.

Two cell populations from the same tissue can differ substantially in redox status, stress resistance and secretory behaviour. So “from umbilical cord” is a starting point, not a specification.

The full comparative plate, across biological character, reported clinical profile and limitations.Fig. 01

Level 01Source

Selection criteria, in full

The PEXT source-cell assessment platform examines four complementary glutathione-related parameters. A population is characterized on all four before it is cleared to produce.

GM

Where does the population sit?

Glutathione Mean Level

The central intracellular glutathione level of the cell population.

Mean or median of FreSHtracer Ratio (FR)

GH

How tightly is it grouped?

Glutathione Heterogeneity

The degree of biological variability within that population.

rCV = rSD ÷ Median · rSD = median(|Xᵢ − median|) × 1.4826

GRC

Can it recover from a hit?

Glutathione Regeneration Capacity

The ability of cells to restore glutathione balance after an oxidative challenge.

%GRC = AUC(oxidant) ÷ AUC(non-treated)

ORC

What fraction holds under stress?

Oxidative Stress Resistant Capacity

The proportion of cells maintaining high glutathione under oxidative stress.

%ORC = (GSH-high cell count ÷ total cell count) × 100

The published parameter definitions with worked examples for each measure.Fig. 01

Level 02Culture

The culture environment is part of the product

Eliminating unnecessary culture components reduces avoidable process variables and gives clearer control over the environment vesicles and conditioned media are generated in. This is a controlled, clean manufacturing strategy, not “organic production.”
Selection-driven, phenol red-free, animal component-free manufacture, end to end.Fig. 02

Level 04 / Stability

Why a lyophilized regenerative powder?

Research shows that appropriate protective formulations can preserve EV concentration, morphology, molecular markers and in-vitro activity under defined conditions. That is a conditional statement, and PEXT treats it as one.

Stability should not be assumed from the word “lyophilized.” It should be demonstrated after reconstitution.

Why is an EV preparation lyophilized at all?
Extracellular vesicles are delicate. Temperature, water, repeated freeze–thaw cycles, buffer composition and storage duration all affect stability. A properly optimized lyophilization converts a liquid preparation into a dry, reconstitutable format that simplifies handling, transport, storage and preparation at the point of use.
Does freeze-drying make a product better?
No. Inadequate formulation or process conditions can cause aggregation, particle loss, membrane alteration or reduced bioactivity. Lyophilization is a process that has to be validated like any other, not a quality claim.
So what should a buyer actually compare?
Not whether a product is lyophilized, but whether its identity, integrity and function remain demonstrable after reconstitution. Which means the comparison that matters is paired: particle recovery and biological function, before versus after.

On the batch record

Residual moisture, reconstitution time, and paired before/after comparisons of particle recovery and biological function are reported per lot.

Batch Passport specification

Level 03Product · labelling & identity

The question we get most: if this is an exosome product, why does the label say fibronectin?

Because an INCI ingredient name and a description of the biology answer two different questions. Conflating them is how this market loses credibility.

Fibronectin is a high-molecular-weight extracellular-matrix glycoprotein involved in cell adhesion, migration, tissue organization and interaction with integrin receptors. Studies show it can also associate with the surface of extracellular vesicles, where it contributes to integrin-dependent binding, cellular uptake and functional cargo delivery.

So fibronectin is not a substitute for a vesicle, and its presence does not mean a preparation is “not an exosome.”

And the part most suppliers leave out

Fibronectin is not a universal exosome marker. Fibronectin alone cannot establish the identity, purity, concentration or biological activity of an EV preparation. Those characteristics require multi-parameter analytical evidence, which is what the batch record is for.

What the INCI name answers
“What standardized ingredient name applies to this material for cosmetic labelling?” INCI nomenclature is a labelling convention. It is not a description of a platform, and appearance in the European Commission’s CosIng database does not by itself constitute product authorization or proof of regulatory approval.
What characterization answers
“What is actually in this preparation, how pure is it, and what does it do?” Answered by particle profile, marker panels, contaminant analysis and potency assays, reported per lot.
The product plate, with the fibronectin rationale as it appears on the platform documentation.Fig. 05

What this platform produces

Two output formats, one selection process

Purified vesicle fraction

PEXT Regenerative Powder

The purified fraction, lyophilized into a stable, reconstitutable powder standardized at 1,000,000 ppm. Presented within the cosmetic framework applicable to its authorized topical use.

Whole secretome

PEXT CM

Instead of isolating a single fraction, PEXT CM keeps the broader spectrum of secreted signals: soluble proteins, ECM components, growth-factor regulatory proteins, redox enzymes, immune-modulatory mediators and EV-associated cargo.

1,205
identified proteins
507
ECM-annotated
33
redox enzymes
29
EV cargo markers
Inside PEXT CM

The other path

When molecular definition matters more than biological complexity

Platform 02 · Recombinant Precision